Literature DB >> 24850742

Enhancement of interferon induction by ORF3 product of hepatitis E virus.

Yuchen Nan1, Zexu Ma1, Rong Wang1, Ying Yu1, Harilakshmi Kannan1, Brenda Fredericksen2, Yan-Jin Zhang3.   

Abstract

UNLABELLED: Hepatitis E virus (HEV) causes both the endemic and epidemic spread of acute hepatitis in many parts of the world. HEV open reading frame 3 (ORF3) encodes a 13-kDa multifunctional protein (vp13) that is essential for HEV infection of animals. The exact role of vp13 in HEV infection remains unclear. In this study, vp13 was found to enhance interferon (IFN) production induced by poly(I · C), a synthetic analog of double-stranded RNA. Poly(I · C) treatment induced a higher level of IFN-β mRNA in HeLa cells stably expressing vp13 than in control cells. Using a luciferase reporter construct driven by the IFN-β promoter, we demonstrated that vp13 enhanced retinoic acid-inducible gene I (RIG-I)-dependent luciferase expression. This enhancement was found to be due to both an increased level of RIG-I protein and its activation. The levels of both endogenous and exogenous RIG-I were increased by vp13 by extension of the half-life of RIG-I. Additionally, vp13 interacts with the RIG-I N-terminal domain and enhances its K63-linked ubiquitination, which is essential for RIG-I activation. Analysis of vp13 deletion constructs suggested that the C-terminal domain of vp13 was essential for the enhancement of RIG-I signaling. In HEV-infected hepatoma cells, wild-type HEV led to a higher level of RIG-I and more poly(I · C)-induced IFN-β expression than did ORF3-null mutants. Analysis of vp13 from four HEV genotypes showed that vp13 from genotype I and III strains boosted RIG-I signaling, while vp13 from genotype II and IV strains had a minimal effect. These results indicate that vp13 enhances RIG-I signaling, which may play a role in HEV invasion. IMPORTANCE: Hepatitis E virus (HEV) is a significant pathogen causing hepatitis in many parts of the world, yet it is understudied compared with other viral hepatitis pathogens. Here we found that the HEV open reading frame 3 product, vp13, enhances interferon induction stimulated by a synthetic analog of double-stranded RNA. This enhancement may play a role in HEV invasion, as vp13 is essential for HEV infection in vivo. The results of this study provide insights into virus-cell interactions during HEV infection. In addition to revealing its possible roles in HEV interference with cellular signaling, these results suggest that the second half of the vp13 sequence can be ligated into the genomes of attenuated live viruses to induce an innate immune response for better protective immunity, as well as a marker for differentiation of vaccinated animals from those infected with the corresponding wild-type viruses.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24850742      PMCID: PMC4135948          DOI: 10.1128/JVI.01228-14

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  46 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Shared and unique functions of the DExD/H-box helicases RIG-I, MDA5, and LGP2 in antiviral innate immunity.

Authors:  Mitsutoshi Yoneyama; Mika Kikuchi; Kanae Matsumoto; Tadaatsu Imaizumi; Makoto Miyagishi; Kazunari Taira; Eileen Foy; Yueh-Ming Loo; Michael Gale; Shizuo Akira; Shin Yonehara; Atsushi Kato; Takashi Fujita
Journal:  J Immunol       Date:  2005-09-01       Impact factor: 5.422

3.  ORF3 protein of hepatitis E virus is not required for replication, virion assembly, or infection of hepatoma cells in vitro.

Authors:  Suzanne U Emerson; Hanh Nguyen; Udana Torian; Robert H Purcell
Journal:  J Virol       Date:  2006-08-23       Impact factor: 5.103

Review 4.  Pathogenesis and treatment of hepatitis e virus infection.

Authors:  Heiner Wedemeyer; Sven Pischke; Michael P Manns
Journal:  Gastroenterology       Date:  2012-05       Impact factor: 22.682

5.  MyD88 is an adaptor protein in the hToll/IL-1 receptor family signaling pathways.

Authors:  R Medzhitov; P Preston-Hurlburt; E Kopp; A Stadlen; C Chen; S Ghosh; C A Janeway
Journal:  Mol Cell       Date:  1998-08       Impact factor: 17.970

Review 6.  The epidemiology of hepatitis E virus infections in developed countries and among immunocompromised patients.

Authors:  Kenrad E Nelson; Brittany Kmush; Alain B Labrique
Journal:  Expert Rev Anti Infect Ther       Date:  2011-12       Impact factor: 5.091

7.  The 3C protein of enterovirus 71 inhibits retinoid acid-inducible gene I-mediated interferon regulatory factor 3 activation and type I interferon responses.

Authors:  Xiaobo Lei; Xinlei Liu; Yijie Ma; Zhenmin Sun; Yaowu Yang; Qi Jin; Bin He; Jianwei Wang
Journal:  J Virol       Date:  2010-06-02       Impact factor: 5.103

8.  In vitro replication of hepatitis E virus (HEV) genomes and of an HEV replicon expressing green fluorescent protein.

Authors:  Suzanne U Emerson; Hanh Nguyen; Judith Graff; David A Stephany; Alicia Brockington; Robert H Purcell
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

9.  The hepatitis E virus open reading frame 3 product interacts with microtubules and interferes with their dynamics.

Authors:  Harilakshmi Kannan; Sumin Fan; Deendayal Patel; Ioannis Bossis; Yan-Jin Zhang
Journal:  J Virol       Date:  2009-04-15       Impact factor: 5.103

10.  Inhibition of replication and transcription activator and latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus by morpholino oligomers.

Authors:  Yan-Jin Zhang; Kai-Yu Wang; David A Stein; Deendayal Patel; Rheba Watkins; Hong M Moulton; Patrick L Iversen; David O Matson
Journal:  Antiviral Res       Date:  2006-06-14       Impact factor: 5.970

View more
  37 in total

Review 1.  Innate Immunity to Enteric Hepatitis Viruses.

Authors:  Zongdi Feng; Stanley M Lemon
Journal:  Cold Spring Harb Perspect Med       Date:  2019-03-01       Impact factor: 6.915

Review 2.  Natural History, Clinical Manifestations, and Pathogenesis of Hepatitis E Virus Genotype 1 and 2 Infections.

Authors:  Rakesh Aggarwal; Amit Goel
Journal:  Cold Spring Harb Perspect Med       Date:  2019-07-01       Impact factor: 6.915

3.  Porcine Reproductive and Respiratory Syndrome Virus Antagonizes JAK/STAT3 Signaling via nsp5, Which Induces STAT3 Degradation.

Authors:  Liping Yang; Rong Wang; Zexu Ma; Yueqiang Xiao; Yuchen Nan; Yu Wang; Shaoli Lin; Yan-Jin Zhang
Journal:  J Virol       Date:  2017-01-18       Impact factor: 5.103

4.  Activities of Thrombin and Factor Xa Are Essential for Replication of Hepatitis E Virus and Are Possibly Implicated in ORF1 Polyprotein Processing.

Authors:  Gayatri D Kanade; Kunal D Pingale; Yogesh A Karpe
Journal:  J Virol       Date:  2018-02-26       Impact factor: 5.103

5.  ISG15 Modulates Type I Interferon Signaling and the Antiviral Response during Hepatitis E Virus Replication.

Authors:  Harini Sooryanarain; Adam J Rogers; Dianjun Cao; Mary Etna R Haac; Yogesh A Karpe; Xiang-Jin Meng
Journal:  J Virol       Date:  2017-09-12       Impact factor: 5.103

6.  Hepatitis E Virus Genotype 3 Genomes from RNA-Positive but Serologically Negative Plasma Donors Have CUG as the Start Codon for ORF3.

Authors:  Heléne Norder; Cristina Galli; Ellen Magnil; Per Sikora; Elisabet Ekvärn; Kristina Nyström; Lars O Magnius
Journal:  Intervirology       Date:  2018-10-02       Impact factor: 1.763

7.  Hepatitis E virus inhibits type I interferon induction by ORF1 products.

Authors:  Yuchen Nan; Ying Yu; Zexu Ma; Sunil K Khattar; Brenda Fredericksen; Yan-Jin Zhang
Journal:  J Virol       Date:  2014-08-06       Impact factor: 5.103

8.  Safflower extract inhibiting apoptosis by inducing autophagy in myocardium derived H9C2 cell.

Authors:  Zhisheng Jia; Yancai Liu; Huailing Su; Ming Li; Min Zhang; Ye Zhu; Tenjiao Li; Youbo Fang; Shimin Liang
Journal:  Int J Clin Exp Med       Date:  2015-11-15

Review 9.  Hepatitis E virus infection: Epidemiology and treatment implications.

Authors:  Ga Young Lee; Kittiyod Poovorawan; Duangnapa Intharasongkroh; Pattaratida Sa-Nguanmoo; Sompong Vongpunsawad; Chintana Chirathaworn; Yong Poovorawan
Journal:  World J Virol       Date:  2015-11-12

10.  Replacement of the hepatitis E virus ORF3 protein PxxP motif with heterologous late domain motifs affects virus release via interaction with TSG101.

Authors:  Scott P Kenney; Jacquelyn L Wentworth; Connie L Heffron; Xiang-Jin Meng
Journal:  Virology       Date:  2015-10-27       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.